AI Terminal
Novonesis AS
Director's Dealing • Jan 27, 2020
3377_rpt_2020-01-27_d7074a34-7e6b-456f-adfe-94273bf778f4.pdf
Director's Dealing
Open in ViewerOpens in native device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| Details of the person discharging managerial responsibilities/person closely associated | Tobias Cornelius Björklund | ||
|---|---|---|---|
| Name | Tina Sejersgård Fanø | +45 3077 8682 [email protected] |
|
| Reason for notification | Carl Ahlgren | ||
| Position/status | Executive Vice President, Agriculture & Bioenergy | +45 3077 2783 | |
| Initial notification/ | Initial notification | [email protected] | |
| amendment | Ulrik Wu Svare | ||
| +45 3077 3187 | |||
| Details of the issuer | [email protected] | ||
| Entity | Novozymes A/S | ||
Details of the transaction(s)
LEI code 529900T6WNZXD2R3JW38
| Description: | |||||
|---|---|---|---|---|---|
| Financial instrument | Shares | ||||
| Identification code | ISIN DK0060336014 | ||||
| Nature of the transaction | Shares sold | ||||
| Place(s) of transaction(s), | |||||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) | ||
| See appendix | See appendix | 11,459 shares | |||
| Aggregated information | Number of shares: 11,459 | ||||
| Average price, DKK: 349.72 | |||||
| Transaction value, DKK: 4,007,404.60 | |||||
| Date of the transaction | 2020-27-01 |
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
January 27, 2020
Contact information
Company announcement No. 5
enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
About Novozymes
Phone: +45 4446 0000
Appendix
| Volume | Price | Venue |
|---|---|---|
| 6,667 | 349.50 | OTC |
| 54 | 350.20 | XCSE |
| 826 | 350.00 | XCSE |
| 109 | 350.00 | XCSE |
| 54 | 349.60 | XCSE |
| 73 | 349.60 | XCSE |
| 204 | 350.00 | XCSE |
| 97 | 350.00 | XCSE |
| 149 | 349.70 | XCSE |
| 118 | 349.70 | XCSE |
| 97 | 349.70 | XCSE |
| 42 | 350.10 | XCSE |
| 160 | 350.10 | XCSE |
| 223 | 350.00 | XCSE |
| 40 | 350.00 | XCSE |
| 150 | 350.00 | XCSE |
| 54 | 350.00 | XCSE |
| 54 | 349.90 | XCSE |
| 40 | 349.90 | XCSE |
| 100 | 349.90 | XCSE |
| 54 | 349.80 | XCSE |
| 180 | 350.10 | XCSE |
| 100 | 350.10 | XCSE |
| 41 | 350.00 | XCSE |
| 79 | 350.00 | XCSE |
| 225 | 350.00 | XCSE |
| 17 | 349.80 | XCSE |
| 150 | 349.80 | XCSE |
| 190 | 349.80 | XCSE |
| 150 | 349.70 | XCSE |
| 54 | 350.10 | XCSE |
| 150 | 350.50 | XCSE |
| 69 | 350.50 | XCSE |
| 96 | 350.40 | XCSE |
| 26 | 350.40 | XCSE |
| 42 | 350.50 | XCSE |
| 96 | 350.50 | XCSE |
| 43 | 350.40 | XCSE |
| 96 | 350.30 | XCSE |
| 140 | 350.30 | XCSE |
| 150 | 350.10 | XCSE |
